SCHEMBL283293

SCHEMBL283293

O=C(Cl)c1cc(C(F)(F)F)ccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.52
ALDH1A1 P00352 2/20 0.48
ALOX15 P16050 1/20 0.48
TMPRSS4 Q9NRS4 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.45
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
DDR1 Q08345 1/20 0.43
GAA P10253 1/20 0.43
IDO1 P14902 1/20 0.42
MEN1 O00255 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
CES1 P23141 1/20 0.41
CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL31028111 0.98 CES2 (0.50) CES2ALDH1A1ALOX15TMPRSS4TRPV1
SCHEMBL8674347 0.93 GAA (0.49) CES2ALDH1A1ALOX15TMPRSS4TRPV1
SCHEMBL8703955 0.86 CES2 (0.41) CES2ALDH1A1ALOX15TMPRSS4TRPV1
SCHEMBL496324 0.85 GAA (0.54) CES2ALDH1A1ALOX15TMPRSS4TRPV1
SCHEMBL29382489 0.82 ALDH1A1 (0.59) CES2ALDH1A1MRGPRX4KDM4EHPGD
SCHEMBL43771 0.82 ALDH1A1 (0.59) CES2ALDH1A1MRGPRX4KDM4EHPGD
SCHEMBL937701 0.81 CES2 (0.72) CES2ALDH1A1TMPRSS4KDM4EHPGD
SCHEMBL20560372 0.81 CES2 (0.43) CES2ALDH1A1TMPRSS4TRPV1MRGPRX4
SCHEMBL29786688 0.81 CES2 (0.52) CES2ALDH1A1ALOX15TMPRSS4TRPV1
SCHEMBL2073688 0.81 CES2 (0.52) CES2ALDH1A1ALOX15TMPRSS4TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 401 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118549482-A Pseudo two-dimensional method for rapidly detecting amines in mixed system19F nuclear magnetic resonance spectroscopy 宁波大学 2024-08-27 CN claimed
WO-2025229046-A1 SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME MOLIUS SAGLIK TEKNOLOJILERI ANONIM SIRKETI (TR) 2025-11-06 WO disclosed
EP-4644375-A1 SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME Molius Saglik Teknolojileri Anonim Sirketi (TR) 2025-11-05 EP disclosed
CN-120152713-A Tricyclic aryl derivatives and compositions and methods thereof 昂胜医疗科技公司 2025-06-13 CN disclosed
CN-119947718-A Tricyclic aryl derivatives, and compositions and methods thereof 昂胜医疗科技公司 2025-05-06 CN disclosed
US-12281057-B2 Carboxamides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-04-22 US disclosed
EP-3651752-B1 CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMA (US) 2024-11-20 EP disclosed
CN-118930454-A Bisamide compound containing hydrazide structure and synthetic method and application thereof 河北威远生物化工有限公司 2024-11-12 CN disclosed
CN-118549482-A Pseudo two-dimensional method for rapidly detecting amines in mixed system19F nuclear magnetic resonance spectroscopy 宁波大学 2024-08-27 CN disclosed
CN-114181199-B 2, 4-disubstituted pyrimidine derivative, preparation method and application thereof 成都赜灵生物医药科技有限公司 2023-09-26 CN disclosed
US-6077850-A USEFUL FOR TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 2000-06-20 US disclosed
WO-2000023433-A1 SUBSTITUTED BENZOPYRAN ANALOGS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 2000-04-27 WO disclosed
US-6034256-A CYCLOOXYGEASE INHIBITOR G.D. SEARLE & CO. (US) 2000-03-07 US disclosed
EP-0977748-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 2000-02-09 EP disclosed
EP-0973936-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC AMINOTHIOETHER ACIDS ELI LILLY AND COMPANY (US) 2000-01-26 EP disclosed
US-5942387-A Combinatorial process for preparing substituted thiophene libraries ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
WO-1998047890-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-10-29 WO disclosed
WO-1998046631-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC MACROCYCLES AND PROCESSES THEREFOR ELI LILLY AND COMPANY (US) 1998-10-22 WO disclosed
WO-1998046786-A1 COMBINATORIAL LIBRARIES OF PEPTIDOMIMETIC AMINOTHIOETHER ACIDS ELI LILLY AND COMPANY (US) 1998-10-22 WO disclosed
EP-0825164-A2 Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12281057-B2 Carboxamides as modulators of sodium channels TRPV1, SCN2A, SCN10A CES2 789/4885ALDH1A1 2665/4885ALOX15 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.